Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 1887-1888, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varner, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varner, M. W.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 1999;45:1887-1888.)
© 1999 American Association for Clinical Chemistry, Inc.


Editorials

Ceruloplasmin and Preterm Premature Rupture of the Membranes

Michael W. Varner

University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT 84132

Premature rupture of the membranes (PROM), defined as rupture of the chorioamniotic membranes before the onset of labor, is a very common clinical problem in human pregnancy. In clinical obstetric terminology, PROM is defined as rupture of the membranes at term (within 3 weeks of the Estimated Date of Confinement, or due date). The reported incidence of PROM in term pregnancy is 8–10%. Approximately one-fourth of PROM cases occur remote from term (i.e., at less than 37 completed gestational weeks) and are termed preterm PROM (often called PPROM).

Term pregnancies complicated by PROM are at increased risk for several complications for mother and fetus. The likelihood of ascending maternal infection, or chorioamnionitis, is directly related to the duration of membrane rupture, increasing from an overall rate of 0.5% to 3–15% with progressive duration of PROM (1). The risk of neonatal sepsis (0.2% for all term newborns) also increases both with the presence of PROM (1%) and with the duration of PROM (3–5% with PROM >24 h). The . . . [Full Text of this Article]


References







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.